Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Corvus Pharmaceuticals Inc banner

Corvus Pharmaceuticals Inc
SWB:C17

Watchlist Manager
Corvus Pharmaceuticals Inc Logo
Corvus Pharmaceuticals Inc
SWB:C17
Watchlist
Price: 12.045 EUR 0.71%
Market Cap: €590.7m
Write Note Create Alert Ask AI

Intrinsic Value

The intrinsic value for Corvus Pharmaceuticals Inc (C17) under the Base Case is 3.594 EUR. Compared with the current market price of 12.045 EUR, the stock appears Overvalued by 70% .

Intrinsic value calculated using DCF
€3.594
Other reference points
Multiples estimate
€2.534
Wall St target
€27.912

Do our valuations actually work? See backtest results .

C17 Intrinsic Value
€3.594
Overvaluation 70%
Intrinsic Value
Price €12.045
Monitor C17
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €2.88
Get notified when the price drops into your buy zone
Current Price €12.05
Intrinsic Value €3.59
Margin of Safety 20% €2.88
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to C17

Fundamental Analysis

Financials
Efficiency

Earnings Waterfall
Corvus Pharmaceuticals Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

CRVS Insider Trading
Buy and sell transactions by insiders

Continue C17 Research

Summary
C17 intrinsic value, competitors valuation, and company profile.
DCF Valuation
C17 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
C17 stock valuation using valuation multiples.
Wall St Estimates
C17 price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
C17 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Corvus Pharmaceuticals Inc listings:
NASDAQ • USD
CRVS
 F • EUR
C17
Discover More
What is the Intrinsic Value of one C17 stock?

The intrinsic value for Corvus Pharmaceuticals Inc (C17) under the Base Case is 3.594 EUR.

Is C17 stock undervalued or overvalued?

Compared with the current market price of 12.045 EUR, the stock appears Overvalued by 70% .

Back to Top
ALPHA SPREAD
Follow us
Join 359,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.